Artemether and Lumefantrine Oral Suspension is a combination antimalarial drug, with artemether and lumefantrine as the main components. The two exert antimalarial effects through a synergistic action: artemether can quickly kill plasmodium schizonts in red blood cells, rapidly controlling malaria symptoms; lumefantrine acts on the exoerythrocytic stage of plasmodia, effectively eliminating residual plasmodia and reducing the risk of recurrence.
Its main applicable scenarios include:
Malaria treatment: Used for the treatment of various types of malaria, especially with significant efficacy against falciparum malaria (including chloroquine-resistant falciparum malaria), and can quickly relieve typical malaria symptoms such as fever, chills, and headache.
This product is an oral suspension with a slightly sweet taste, suitable for children, patients with difficulty swallowing, and adults. Its absorption is not affected by food (but co-administration with high-fat foods can enhance absorption). The specific dosage needs to be adjusted according to the patient's age, weight, and severity of the condition, and must be taken for a full course of treatment as prescribed by a doctor to ensure the complete elimination of plasmodia.
